Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations

被引:42
作者
Johannsdottir, Sunna [1 ]
Jansook, Phatsawee [2 ]
Stefansson, Einar [3 ]
Loftsson, Thorsteinn [1 ]
机构
[1] Univ Iceland, Fac Pharmaceut Sci, IS-107 Reykjavik, Iceland
[2] Chulalongkorn Univ, Fac Pharmaceut Sci, Bangkok, Thailand
[3] Univ Iceland, Natl Univ Hosp, Fac Med, Dept Ophthalmol, IS-107 Reykjavik, Iceland
关键词
Cyclosporin A; Cyclodextrins; Eye drops; Dry eye disease; Nanoparticles; GAMMA-CYCLODEXTRIN; PHARMACEUTICAL APPLICATIONS; SOLUBILIZATION; COMPLEXES; DELIVERY; KINETICS; DRUGS;
D O I
10.1016/j.ijpharm.2015.07.040
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cyclosporin A (CyA) is a lipophilic, cyclic polypeptide drug with anti-inflammatory properties. It is used in topical treatment of dry eyes and is now commercially available in oil based surfactant containing eye drops. Surfactants can irritate the eye surface causing burning, itching and irritation of the conjunctiva, and oil-based drops can result in blurred vision. Thus, the aim of this study was to develop surfactant free aqueous 0.05% (w/v) CyA eye drops where the drug is present in an aqueous vehicle containing CyA/cyclodextrin (CyA/CD) nanoparticles. The effects of the natural alpha-, beta- and gamma-cyclodextrins (alpha CD, beta CD and gamma CD), as well as of the water soluble hydroxypropyl derivatives of gCD and aCD (HP gamma CD, HP alpha CD) and randomly methylated beta CD (RM beta CD), were determined in pure water. aCD had the best solubilizing effect increasing the solubility of CyA above 0.05% upon addition of only 5% (w/v) alpha CD. gamma CD did not have as good solubilizing effect but was tested further due to its superior ability to form nanoparticles and its favorable toxicological profile. Seven eye drop formulations were prepared and tested. All contained 0.05% (w/v) CyA in addition to polyvinyl alcohol, benzalkonium chloride, disodium edetate and various amounts of CD (alpha CD, gamma CD and mixtures thereof). When the formulation contained only alpha CD most of the drug was dissolved but some small aggregates were formed with hydrodynamic diameter of about 6 and 155 nm. When the formulation contained only gamma CD negligible CyA/CD complexation occurred with most of the drug present as solid CyA particles. When the formulation contained a mixture of alpha CD and gamma CD, where alpha CD concentration was at least 3% (w/v), the entire drug content was dissolved in the media under formation of relatively large (100-2000 nm) CyA/CD nanoparticles. alpha CD solubilized the drug while gamma CD enhanced nanoparticle formation. The effect of polyvinyl alcohol, benzalkonium chloride and disodium edetate on the nanoparticle formation was also investigated and shown to have positive effect on the aggregate formation. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:86 / 95
页数:10
相关论文
共 50 条
  • [1] Formulations and toxicologic in vivo studies of aqueous cyclosporin A eye drops with cyclodextrin nanoparticles
    Johannsdottir, Sunna
    Kristinsson, Johannes K.
    Fulop, Zoltan
    Asgrimsdottir, Gudrun
    Stefansson, Einar
    Loftsson, Thorsteinn
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 529 (1-2) : 486 - 490
  • [2] Poly(HEMA)/Cyclodextrin-Based Hydrogels for Subconjunctival Delivery of Cyclosporin A
    Basbag, A. Berna
    Gumusderelioglu, Menemse
    Simsek, Murat
    Guner, Ali
    JOURNAL OF APPLIED POLYMER SCIENCE, 2014, 131 (12)
  • [3] Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B
    Jansook, Phatsawee
    Pichayakorn, Wiwat
    Muankaew, Chutimon
    Loftsson, Thorsteinn
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (09) : 1446 - 1454
  • [4] Cyclodextrin-Based Porous Nanocapsules
    Wang, Youqing
    Han, Baohang
    CHINESE JOURNAL OF CHEMISTRY, 2013, 31 (05) : 569 - 576
  • [5] Cyclodextrin-based dermatological formulations: Dermopharmaceutical and cosmetic applications
    Ferreira, Laura
    Mascarenhas-Melo, Filipa
    Rabaca, Sofia
    Mathur, Ankita
    Sharma, Ankur
    Giram, Prabhanjan S.
    Pawar, Kiran D.
    Rahdar, Abbas
    Raza, Faisal
    Veiga, Francisco
    Mazzola, Priscila Gava
    Paiva-Santos, Ana Claudia
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2023, 221
  • [6] Aqueous eye drop formulations: Cyclodextrins as enabling excipients
    Pilotaz, Frederic
    Loftsson, Thorsteinn
    ANNALES PHARMACEUTIQUES FRANCAISES, 2024, 82 (06): : 994 - 1007
  • [7] Cyclodextrin-based nanostructures
    Narayanan, Ganesh
    Shen, Jialong
    Matai, Ishita
    Sachdev, Abhay
    Boy, Ramiz
    Tonelli, Alan E.
    PROGRESS IN MATERIALS SCIENCE, 2022, 124
  • [8] Cyclodextrins in eye drop formulations
    Stefánsson, E
    Loftsson, T
    JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2002, 44 (1-4) : 23 - 27
  • [9] Development of Cyclodextrin-based Cancer Treatment
    Motoyama, Keiichi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2015, 135 (11): : 1291 - 1298
  • [10] Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery
    Muankaew, Chutimon
    Loftsson, Thorsteinn
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 46 - 55